pLJC2-GPT2-3xFLAG Citations (1)

Originally described in: CRISPR screens in physiologic medium reveal conditionally essential genes in human cells.
Rossiter NJ, Huggler KS, Adelmann CH, Keys HR, Soens RW, Sabatini DM, Cantor JR Cell Metab. 2021 Feb 23. pii: S1550-4131(21)00061-9. doi: 10.1016/j.cmet.2021.02.005. PubMed Journal

---

Articles Citing pLJC2-GPT2-3xFLAG

Articles
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers. Sergi B, Yuksel-Catal N, Ozcan SC, Syed H, Duvvuri U, Kiselyov K, Acilan C. Cell Death Dis. 2025 Aug 8;16(1):600. doi: 10.1038/s41419-025-07900-w. PubMed

If you have published an article using this material, please email us at to have your article added to this page.